Orathai Dangsawat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Orathai Dangsawat has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Luu Tang Phuc Khang
Aquatic Biotechnology Laboratory, Department of Animal and Aquatic Sciences, Faculty of Agriculture Chiang Mai University Chiang Mai Thailand
4 shared publications - Nguyen Vu Linh
Department of Animal and Aquatic Sciences, Faculty of Agriculture, Chiang Mai University, Chiang Mai 50200, Thailand
4 shared publications - Patima Permpoonpattana
Department of Agricultural Science and Technology, Faculty of Innovative Agriculture, Fisheries and Food, Prince of Songkla University, Surat Thani Campus, Surat Thani 84000, Thailand
4 shared publications - Nguyen Dinh-Hung
Aquaculture Pathology Laboratory, School of Animal & Comparative Biomedical Sciences, The University of Arizona, Tucson, AZ 85721, USA
3 shared publications - Papungkorn Sangsawad
School of Animal Technology and Innovation, Institute of Agricultural Technology, Suranaree University of Technology, Nakhon Ratchasima, Thailand
3 shared publications - Phatthanaphong Therdtatha
Specialized Research in Microbiome and Metabolome for Health Laboratory, Division of Biotechnology, Faculty of Agro-Industry, Chiang Mai University, Chiang Mai, Thailand
3 shared publications
Latest Publications
- Open Access
- 16 March 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (3) , 373
Dietary Encapsulation of a Novel Lysinibacillus sp. PWR01 Probiotic Modulates Growth, Antioxidant, Immune Gene Expression, and Gut Health in Nile tilapia (Oreochromis niloticus) Against Aeromonas hydrophila Infection
Encapsulated probiotics, which are promising approaches for improving aquaculture species’ performance and health, have incompletely characterized dose-dependent physiological and immunological effects. This study represents the first report evaluating the probiotic efficacy of a novel encapsulated Lysinibacillus sp. PWR01, originally isolated from rubber latex nodules, in Nile tilapia (Oreochromis niloticus). A total of 300 Nile tilapia (10.80 ± 0.07 g) was allocated to four experimental groups receiving 0, 104, 105, and 106 CFU/g of encapsulated Lysinibacillus sp. PWR01 in their diet. At 8 weeks of the feeding trial, growth performance, feed utilization, serum antioxidant status, intestinal bacterial counts and immune-related gene expression were analyzed. Results demonstrated that fish fed 106 CFU/g achieved a final weight of 51.48 g, representing a 9.88% increase compared with the control (46.85 g), while weight gain (WG) improved by 12.82% and specific growth rate (SGR) by 6.34%. Feed conversion ratio (FCR) was reduced by up to 18.42% at 105 CFU/g relative to the control. Encapsulated groups enhanced serum superoxide dismutase activity without altering malondialdehyde levels, increased total intestinal bacterial and lactic acid bacteria counts, and selectively upregulated TLR2 and MHC II mRNA transcript levels. Histological analysis further revealed increased intestinal villus height and width in encapsulated-fed groups, while liver architecture remained normal across treatments. Multivariate analyses demonstrated strong positive associations among growth performance, gut microbiota enrichment, and immune gene expression. Resistance to Aeromonas hydrophila infection was significantly improved at higher dietary doses, with post-challenge survival reaching 61.67–75% in supplemented groups versus 45.00% in controls. These findings demonstrate that latex-derived Lysinibacillus sp. PWR01 acts as a strain-specific immunomodulatory probiotic that enhances growth, antioxidant capacity, microbial community balance, and disease resistance to Nile tilapia. Future studies should investigate the role of the Nrf2 antioxidant pathway, clarify TLR2-mediated immune signaling, and assess gut microbiota–immune system interactions within commercial-scale production systems.
- 16 March 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (3) , 373
Open AccessDietary Encapsulation of a Novel Lysinibacillus sp. PWR01 Probiotic Modulates Growth, Antioxidant, Immune Gene Expression, and Gut Health in Nile tilapia (Oreochromis niloticus) Against Aeromonas hydrophila Infection
Encapsulated probiotics, which are promising approaches for improving aquaculture species’ performance and health, have incompletely characterized dose-dependent physiological and immunological effects. This study represents the first report evaluating the probiotic efficacy of a novel encapsulated Lysinibacillus sp. PWR01, originally isolated from rubber latex nodules, in Nile tilapia (Oreochromis niloticus). A total of 300 Nile tilapia (10.80 ± 0.07 g) was allocated to four experimental groups receiving 0, 104, 105, and 106 CFU/g of encapsulated Lysinibacillus sp. PWR01 in their diet. At 8 weeks of the feeding trial, growth performance, feed utilization, serum antioxidant status, intestinal bacterial counts and immune-related gene expression were analyzed. Results demonstrated that fish fed 106 CFU/g achieved a final weight of 51.48 g, representing a 9.88% increase compared with the control (46.85 g), while weight gain (WG) improved by 12.82% and specific growth rate (SGR) by 6.34%. Feed conversion ratio (FCR) was reduced by up to 18.42% at 105 CFU/g relative to the control. Encapsulated groups enhanced serum superoxide dismutase activity without altering malondialdehyde levels, increased total intestinal bacterial and lactic acid bacteria counts, and selectively upregulated TLR2 and MHC II mRNA transcript levels. Histological analysis further revealed increased intestinal villus height and width in encapsulated-fed groups, while liver architecture remained normal across treatments. Multivariate analyses demonstrated strong positive associations among growth performance, gut microbiota enrichment, and immune gene expression. Resistance to Aeromonas hydrophila infection was significantly improved at higher dietary doses, with post-challenge survival reaching 61.67–75% in supplemented groups versus 45.00% in controls. These findings demonstrate that latex-derived Lysinibacillus sp. PWR01 acts as a strain-specific immunomodulatory probiotic that enhances growth, antioxidant capacity, microbial community balance, and disease resistance to Nile tilapia. Future studies should investigate the role of the Nrf2 antioxidant pathway, clarify TLR2-mediated immune signaling, and assess gut microbiota–immune system interactions within commercial-scale production systems.
- Open Access
- 1 January 2025
- Published by Wiley in International Journal of Microbiology
- Vol. 2025 (1)
Co‐Encapsulated Probiotic Bacillus aryabhattai CKNJH11 With Algae‐Derived Polysaccharides on Growth Performance and Immunity in Asian Seabass ( Lates calcarifer )
Antimicrobial resistance and environmental impacts have driven the search for effective nonantibiotic strategies in aquaculture. In this study, Bacillus aryabhattai strain CKNJH11 was isolated from shrimp pond sediment and systematically evaluated its suitability as a probiotic both in vitro and in vivo experiments. The results revealed that CKNJH11 spores formed with 95.7% efficiency, survived extreme gastric (pH 2.0, 64.9% viability) and bile salt (5%, 78.1% viability) conditions, and inhibited biofilm formation by Pseudomonas aeruginosa and Vibrio parahaemolyticus by 58.3% and 59.9%, respectively. Hemolysis tests and antibiotic‐susceptibility profiling confirmed the strain’s safety. To assess its performance in fish, 120 Asian seabass juveniles (initial weight 13.50 ± 0.35 g) were randomly assigned to four diets (1 × 10 6 CFU/g) as a no‐probiotic control, unformulated spores, alginate‐encapsulated spores, and spores co‐encapsulated with Gracilaria fisheri polysaccharides. After 8 weeks, the co‐encapsulated group exhibited the greatest improvements in growth (60.7 ± 1.98 g weight gain (WG) vs. 38.6 ± 1.34 g in controls; p < 0.05), feed conversion ratio (FCR, 5.67 ± 0.18 vs. 8.13 ± 0.37), and immune indices (elevated leukocyte counts and hemoglobin levels). Gut microbiota analysis confirmed successful colonization by B. aryabhattai (3.75–3.93 log CFU/g) and a 60%–75% decline in Vibrio counts ( p < 0.05). The enhanced stability and activity afforded by alginate protection combined with prebiotic polysaccharides underscores the potential of this formulation as a sustainable biocontrol agent in aquaculture health management.
- 1 January 2025
- Published by Wiley in International Journal of Microbiology
- Vol. 2025 (1)
Open AccessCo‐Encapsulated Probiotic Bacillus aryabhattai CKNJH11 With Algae‐Derived Polysaccharides on Growth Performance and Immunity in Asian Seabass ( Lates calcarifer )
Antimicrobial resistance and environmental impacts have driven the search for effective nonantibiotic strategies in aquaculture. In this study, Bacillus aryabhattai strain CKNJH11 was isolated from shrimp pond sediment and systematically evaluated its suitability as a probiotic both in vitro and in vivo experiments. The results revealed that CKNJH11 spores formed with 95.7% efficiency, survived extreme gastric (pH 2.0, 64.9% viability) and bile salt (5%, 78.1% viability) conditions, and inhibited biofilm formation by Pseudomonas aeruginosa and Vibrio parahaemolyticus by 58.3% and 59.9%, respectively. Hemolysis tests and antibiotic‐susceptibility profiling confirmed the strain’s safety. To assess its performance in fish, 120 Asian seabass juveniles (initial weight 13.50 ± 0.35 g) were randomly assigned to four diets (1 × 10 6 CFU/g) as a no‐probiotic control, unformulated spores, alginate‐encapsulated spores, and spores co‐encapsulated with Gracilaria fisheri polysaccharides. After 8 weeks, the co‐encapsulated group exhibited the greatest improvements in growth (60.7 ± 1.98 g weight gain (WG) vs. 38.6 ± 1.34 g in controls; p < 0.05), feed conversion ratio (FCR, 5.67 ± 0.18 vs. 8.13 ± 0.37), and immune indices (elevated leukocyte counts and hemoglobin levels). Gut microbiota analysis confirmed successful colonization by B. aryabhattai (3.75–3.93 log CFU/g) and a 60%–75% decline in Vibrio counts ( p < 0.05). The enhanced stability and activity afforded by alginate protection combined with prebiotic polysaccharides underscores the potential of this formulation as a sustainable biocontrol agent in aquaculture health management.
- Open Access
- 2 December 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (12) , 2476
Genomic Characterization of Bacillus sp. THPS1: A Hot Spring-Derived Species with Functional Features and Biotechnological Potential
Bacillus sp. THPS1 is a novel strain isolated from a high-temperature hot spring in Thailand, exhibiting distinctive genomic features that enable adaptation to an extreme environment. This study aimed to characterize the genomic and functional attributes of Bacillus sp. THPS1 to understand its adaptation strategies and evaluate its potential for biotechnological applications. The draft genome is 5.38 Mbp with a GC content of 35.67%, encoding 5606 genes, including those linked to stress response and sporulation, which are essential for survival in high-temperature conditions. Phylogenetic analysis and average nucleotide identity (ANI) values confirmed its classification as a distinct species within the Bacillus genus. Pangenome analysis involving 19 others closely related thermophilic Bacillus species identified 1888 singleton genes associated with heat resistance, sporulation, and specialized metabolism, suggesting adaptation to nutrient-deficient, high-temperature environments. Genomic analysis revealed 12 biosynthetic gene clusters (BGCs), including those for polyketides and non-ribosomal peptides, highlighting its potential for synthesizing secondary metabolites that may facilitate its adaptation. Additionally, the presence of three Siphoviridae phage regions and 96 mobile genetic elements (MGEs) suggests significant genomic plasticity, whereas the existence of five CRISPR arrays implies an advanced defense mechanism against phage infections, contributing to genomic stability. The distinctive genomic features and functional capacities of Bacillus sp. THPS1 make it a promising candidate for biotechnological applications, particularly in the production of heat-stable enzymes and the development of resilient bioformulations.
- 2 December 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (12) , 2476
Open AccessGenomic Characterization of Bacillus sp. THPS1: A Hot Spring-Derived Species with Functional Features and Biotechnological Potential
Bacillus sp. THPS1 is a novel strain isolated from a high-temperature hot spring in Thailand, exhibiting distinctive genomic features that enable adaptation to an extreme environment. This study aimed to characterize the genomic and functional attributes of Bacillus sp. THPS1 to understand its adaptation strategies and evaluate its potential for biotechnological applications. The draft genome is 5.38 Mbp with a GC content of 35.67%, encoding 5606 genes, including those linked to stress response and sporulation, which are essential for survival in high-temperature conditions. Phylogenetic analysis and average nucleotide identity (ANI) values confirmed its classification as a distinct species within the Bacillus genus. Pangenome analysis involving 19 others closely related thermophilic Bacillus species identified 1888 singleton genes associated with heat resistance, sporulation, and specialized metabolism, suggesting adaptation to nutrient-deficient, high-temperature environments. Genomic analysis revealed 12 biosynthetic gene clusters (BGCs), including those for polyketides and non-ribosomal peptides, highlighting its potential for synthesizing secondary metabolites that may facilitate its adaptation. Additionally, the presence of three Siphoviridae phage regions and 96 mobile genetic elements (MGEs) suggests significant genomic plasticity, whereas the existence of five CRISPR arrays implies an advanced defense mechanism against phage infections, contributing to genomic stability. The distinctive genomic features and functional capacities of Bacillus sp. THPS1 make it a promising candidate for biotechnological applications, particularly in the production of heat-stable enzymes and the development of resilient bioformulations.